Team EsophaHealers introduces an innovative solution to the challenges faced by achalasia patients and gastroenterologists through EndoLatch, a revolutionary device designed to streamline esophageal balloon dilation procedures. Achalasia, with 300 adults being diagnosed in the United States annually, presents a formidable condition characterized by the narrowing of the esophagus, resulting in profound difficulties in swallowing, accompanied by heartburn, chest pain, and related complications.
Conventional treatments involve esophageal balloon dilation, but existing limitations in endoscope size restrict the use of larger balloons. This necessitates costly and time-consuming X-ray and guidewire procedures. EndoLatch addresses this critical issue by seamlessly integrating the endoscope and large balloon dilation catheter, offering a user-friendly assembly and direct vision during procedures. Notably, the device has demonstrated a 100% success rate in staying secure to both the scope and balloon during insertion and removal. Moreover, EndoLatch’s innovative design allows for the simultaneous use of large balloons and endoscopes, providing a view greater than 120 degrees during balloon utilization. The device not only simplifies procedures but also enhances efficiency without compromising the field of view or usability.
With an annual estimate of 6.1 million upper endoscopic procedures in the United States, EndoLatch promises significant benefits for key stakeholders, including gastroenterologists and patients. The device eliminates the need for additional X-ray and guidewire procedures, reducing both procedure time and costs. Current average costs for upper endoscopic procedures and wire-guided upper endoscopic procedures are $1,200 and $830, respectively. EndoLatch aims to cut procedure costs by approximately 30%.